Vistagen Therapeutics, Inc. earnings per share and revenue

VTGN earnings per share for the last quarter are -0.54 USD whereas the estimation was -0.48 USD which accounts for -13.27% surprise. Company revenue for the same period amounts to 258.00 k USD despite the estimated figure of 364.25 k USD. Estimated earnings per share for the next quarter are -0.49 USD, and revenue is expected to reach 364.43 k USD. Also watch annual changes over time to get a bigger picture of VTGN earnings per share and revenue dynamics.